Delivery Order SPE2DB24D2205-SPE2DB24FDYDN
Award Date
8/8/24
Potential Completion Date
8/29/24
Potential Value
$49K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to AmerisourceBergen Drug Corporation's Corporate Office division. The $32,448.80 firm-fixed-price delivery order is for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with an ultimate completion date of June 24, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award for $32,448.80 was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, to provide TAKHZYRO 300 MG/2 ML SYRINGE 2ML. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of December 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,342.56 firm fixed price delivery order is for TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,448.80 firm fixed-price delivery order is for the supply of TAKHZYRO 300 MG/2 ML syringes, a specialty medication used for the treatment of hereditary angioedema. The award has an ultimate completion date of May 14, 2024 and was made on April 23, 2024. This delivery order is a part of Amerisourcebergen's...
This federal contract award, with a ceiling value of $32,448.80, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a completion date of May 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a ceiling value of $33,570.26 and an ultimate completion date of December 12, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $32,448.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a completion date of July 9, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans...
This federal contract award SPE2DB20D3103|SPE2DB24FN9R7 is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564735336 - TAKHZYRO 300 MG/2 ML SYRINGE 2ML. The $32,448.80 firm fixed price contract has a completion date of June 17, 2024. The award is not set aside and is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $32,448.80 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the provision of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a completion date of March 18, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,448.80 firm fixed price delivery order is for the drug Takhzyro, a 300 mg/2 ml syringe product. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...